Floatz logo

(±)-FTC

HIV Infections

José Antonio Mata MarínSmall moleculePhase 4 / ApprovedActive
BB
71/ 100
Provisional rating · Methodology v0.2

Rating breakdown

Clinical Evidence
64/ 100
Competitive Position
81/ 100

Competitive context

61 Active assets in the HIV Infections cohort.

Asset / SponsorPhaseRating
Raltegravir
Helsinki University Central Hospital
Phase 4A
ZIDOVUDINE
International Maternal Pediatric Adolescent AIDS Clinical Trials Group
Phase 4BBB
Efavirenz
The Cleveland Clinic
Phase 4BBB
RITONAVIR
Giovanni Di Perri
Phase 4BBB
Dolutegravir
Instituto Mexicano del Seguro Social
Phase 4BBB

View all 50 →

Same molecule, other indications

(±)-FTC is also rated in:

HIV infectious diseaseDormant
BB
Indicative ·
66 / 100
View asset →
fatty liver diseaseDormant
BB
Indicative ·
66 / 100
View asset →
Impaired CognitionDormant
BB
Indicative ·
66 / 100
View asset →

Need depth?

Order a full diligence report on this asset.

Order report →

Are you the sponsor?

Submit your data room for a Verified Rating. The public-data rating remains visible alongside.

Contact →